Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06597331 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital

Study acronym: CATCH
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 31, 2026 → Dec 31, 2027
See other at-risk trials from Sahlgrenska University Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2026 to Dec 31, 2027 Show 6 more changesShow less
    • Study completion pushed from Sep 1, 2027 to Sep 1, 2028
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
    • Study description shortened, about 5 words
  2. Study description revised
    • Site contact updated
    • Study title revised
    v3
  3. Start date changed from estimate of Sep 12, 2024 to Sep 23, 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sahlgrenska University Hospital
80 trials monitored
See 2 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
COPD
1,119 trials monitored
See 34 trials at risk
The goal of this prospective observational study is to investigate to what extent acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) triggers Takotsubo-stunning, and how this affects the outcome for these patients. The main questions it aims to answer are: 1. What is cumulative incidence of Takotsubo-stunning in patients hospitalized for AE-COPD at Sahlgrenska University Hospital/S (Gothenburg, Sweden)? 2. Among patients hospitalized for AE-COPD at Sahlgrenska University Hospital/S, what is the risk of in-hospital clinical manifestations of acute heart failure in patients with Takotsubo-stunning compared to those without?
Trial Details
NCT Number NCT06597331
Lead Sponsor Sahlgrenska University Hospital
Conditions
(from sponsor)		 Chronic Obstructive Pulmonary Disease, Takotsubo Cardiomyopathy, Acute Heart Failure
Related terms Pulmonary Disease, Chronic Obstructive, Takotsubo Cardiomyopathy
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov